英文論文
- 2024
- 2023
- 2022
- 2021
- 2020
- 2019
- 2018
- 2017
- 2016
- 2015
- 2014
- 2013
- 2012
- 2011
- 2010
- 2009
- 2008
- 2007
- 2006
- 2005
- 2004
2015
Hatano E, Kanai M, Nagano H, Ioka T.
Clinical study of new chemotherapy regimen for biliary tract cancer.
Nihon Rinsho. 2015 Mar;73 Suppl 3:805-8.
Kitayama H, Tsuji Y, Sugiyama J, Doi A, Kondo T, Hirayama M.
Efficacy of palonosetron and 1-day dexamethasone in moderately emetogenic chemotherapy compared with fosaprepitant, granisetron, and dexamethasone: a prospective randomized crossover study.
Int J Clin Oncol. 20:1051- 1056, 2015.
Kanai M, Hatano E, Kobayashi S, Fujiwara Y, Marubashi S, Miyamoto A, Shiomi H, Kubo S, Ikuta S, Yanagimoto H, Terajima H, Ikoma H, Sakai D, Kodama Y, Seo S, Morita S, Ajiki T, Nagano H, Ioka T.
A multi-institution phase II study of gemcitabine/cisplatin/S-1 (GCS) combination chemotherapy for patients with advanced biliary tract cancer (KHBO 1002).
Cancer Chemother Pharmacol. 2015 Feb; 75(2):293-300.
Nomura M, Oze I, Abe T, Komori A, Narita Y, Masuishi T, Taniguchi H, Kadowaki S, Ura T, Andoh M, Kawai R, Uemura N, Ishihara M, Tanaka T, Tajika M, Niwa Y, Muro K, Muto M.
Impact of docetaxel in addition to cisplatin and fluorouracil as neoadjuvant treatment for resectable stage III or T3 esophageal cancer: a propensity score-matched analysis.
Cancer Chemother Pharmacol 2015 Aug;76(2):357-63.
Osamu kikuchi, Shinya Ohashi, Yukie Nakai, Shunsaku Nakagawa, Kazuaki Matsuoka, Takashi Kobunai, Teiji Takechi, Yusuke Amanuma, Masahiro Yoshioka, Tomomi Ida, Yoshihiro Yamamoto, Yasushi Okuno,Shin’ichi Miyamoto, Hiroshi Nakagawa, Kazuo Matsubara, Tsutomu Chiba, and Manabu Muto.
Novel 5-fluorouracil-resistant human esophageal squamous cell carcinoma cells with dihydropyrimidine dehydrogenase overexpression.
American Journal of Cancer Research 2015 Jul 15;5(8):2431-40. eCollection 2015.
Ichiro Tateya, Shuko Morita, Manabu Muto, Shinichi Miyamoto, Tomomasa Hayashi, Makiko Funakoshi, Ikuo Aoyama, Shigeru Hirano, Morimasa Kitamura, Seiji Ishikawa, Yo Kishimoto, Mami Morita, Patnarin Mahattanasakul, Satoshi Morita, Juishi Ito
Magnifying endoscope with NBI topredict the depth of invasion in laryngo-pharyngeal cancer
Laryngoscope 125(5):1124-1129, 2015.
Kozo Katanaoka, Ikuo Aoyama, Junnki Mizusawa, Junko Eba, Keiko Minashi, Tomonori Yano Masaki Tanaka, Noboru Hanaoka, Hiroshi Katayama, Kohei Takizawa, Haruhiko Fukuda, Manabu Muto on behalf of the Gastrointestinal Endoscopy Study Group(GIESG)of the Japan Clinical Oncology Group.
A randomized controlled Phase II/III study comparing endoscopic balloon dilation combined with steroid injection versus radial incision and cutting combined with steroid injection for refractory anastomotic stricture after esophagectomy:
Jpn J Clin Oncol. 2015 Apr;45(4):385-9.
Tomonori Mizutani, Masaki Tanaka, Junko Eba, Junki Mizusawa, Haruhiko Fukuda, Nonobu Hanaoka, Manabu Takeuchi, Ikuo Aoyama, Takashi Kojima, Kohei Takizawa, Hiroyuki Ono, Manabu Muto.
A Phase III study of oral steroid administration versus local steroid injection therapy for the prevention of esophageal stricture after endoscopic submucosal dissection (JCOG1217, Steroid EESD P3)
Jpn J Clin Oncol 45(11):1087-1090, 2015.
Hatano E, Okuno M, Nakamura K, Ishii T, Seo S, Taura K, Yasuchika K, Yazawa T, Zaima M, Kanazawa A, Terajima H, Kaihara S, Adachi Y, Inoue N, Furumoto K, Manaka D, Tokka A, Furuyama H, Doi K, Hirose T, Horimatsu T, Hasegawa S, Matsumoto S, Sakai Y, Uemoto S.
Conversion to complete resection with mFOLFOX6 with bevacizumab or cetuximab based on K-ras status for unresectable colorectal liver metastasis (BECK study)
J Hepatobiliary Pancreat Sci 22(8):634-645, 2015
Horimatsu T, Sano Y, Tanaka S, Kawamura T, Saito S, Iwatate M, Oka S, Uno K, Yoshimura K, Ishikawa H, Muto M, Tajiri H.
Next-generation narrow band imaging system for colonic polyp detection: a prospective multicenter randomized trial
Int J Colorectal Dis. 30(7):947-54